ATM c.1409C>G ;(p.S470*)

Variant ID: 11-108121601-C-G

NM_000051.3(ATM):c.1409C>G;(p.S470*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The BRCA2 mutation status shapes the immune phenotype of prostate cancer.

Cancer Immunology, Immunotherapy : Cii
Jenzer, Maximilian M; Keß, Peter P; Nientiedt, Cathleen C; Endris, Volker V; Kippenberger, Maximilian M; Leichsenring, Jonas J; Stögbauer, Fabian F; Haimes, Josh J; Mishkin, Skyler S; Kudlow, Brian B; Kaczorowski, Adam A; Zschäbitz, Stefanie S; Volckmar, Anna-Lena AL; Sültmann, Holger H; Jäger, Dirk D; Duensing, Anette A; Schirmacher, Peter P; Hohenfellner, Markus M; Grüllich, Carsten C; Stenzinger, Albrecht A; Duensing, Stefan S
Publication Date: 2019-10

Variant appearance in text: ATM: Ser470*
PubMed Link: 31549213
Variant Present in the following documents:
  • Main text
  • 262_2019_Article_2393.pdf
View BVdb publication page



Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Heliyon
Deng, Qinfang Q; Xie, Boxiong B; Wu, Leilei L; Ji, Xianxiu X; Li, Chao C; Feng, Li L; Fang, Qiyu Q; Bao, Yuchen Y; Li, Jialu J; Jin, Shengnan S; Ding, Chunming C; Li, Yixue Y; Zhou, Songwen S
Publication Date: 2018-12

Variant appearance in text: ATM: S470X
PubMed Link: 30603682
Variant Present in the following documents:
  • mmc2.xlsx, sheet 1
View BVdb publication page